Reporter Sept 26 2014

red laser beam
October 1, 2014

Optical imaging in drug therapy screens

A non-invasive imaging tool could test potential cancer therapies quickly to personalize therapy for patients.

By VUMC News and Communications
brain and lightning
September 30, 2014

Seizure mutation impairs receptor

Defects in the production of certain receptors are linked to the pathogenesis of genetic epilepsies and fever-induced seizures.

By Yan Su
September 26, 2014

Biomarker for diabetic eye disease

A person’s mitochondrial gene “signature” could predict risk for diabetic retinopathy and guide early intervention strategies.

By Leigh MacMillan
September 25, 2014

A path to sarcoidosis treatment

Vanderbilt investigators identify a new therapeutic target for the inflammatory lung disease sarcoidosis.

By VUMC News and Communications
September 25, 2014

VUMC well positioned to move forward: Balser

By Bill Snyder
September 25, 2014

Elevate town hall series kicks off Sept. 30

Beginning Tuesday, Sept. 30, members of Vanderbilt University Medical Center’s leadership team will hold a series of 45-minute town hall presentations that all faculty and staff are encouraged to attend.

By VUMC News and Communications
September 25, 2014

Bradfords’ strong support bolsters melanoma research

When something attacks you, you want to attack it back. That’s how Lillian “Tooty” Bradford views her late husband James “Jimmy” Bradford Jr.’s decision to make an initial gift to fund melanoma research at Vanderbilt-Ingram Cancer Center (VICC).
By Christina Echegaray
September 25, 2014

Annual Flulapalooza event happens Oct. 1

Less than 10 seconds — that’s all it takes to roll up your sleeve and be part of next week’s Flulapalooza, Vanderbilt University Medical Center’s mass flu vaccination event that three years ago more than doubled the world record for the total number of vaccinations given in an eight-hour period.
By Nancy Humphrey
September 25, 2014

Cancer progress report calls for added research support

There are now approximately 14.5 million cancer survivors in the United States, thanks in large part to advances in cancer research and the development of new anti-cancer therapies.
By VUMC News and Communications
September 25, 2014

Churchwell to depart VHVI; Clair to assume interim role

Keith Churchwell, M.D., executive director and chief medical officer for the Vanderbilt Heart and Vascular Institute (VHVI), is departing Vanderbilt and will join Yale-New Haven Health System as vice president and executive director of Cardiovascular Services on Dec. 1.
By John Howser
September 25, 2014

Doherty set for next Discovery Lecture

Nobel laureate Peter Doherty, Ph.D., who discovered how the immune system recognizes virus-infected cells, will deliver the next Flexner Discovery Lecture on Thursday, Oct. 2.
By Leigh MacMillan
September 25, 2014

Orthopaedic programs honored

Vanderbilt Orthopaedics has been named in the Becker’s Hospital Review list of 125 Hospitals and Health Systems With Great Orthopedic Programs.
By VUMC News and Communications
September 25, 2014

Student-run Shade Tree Clinic debuts ophthalmology service

When the Shade Tree Clinic first opened its doors in 2005 the patients received primary care services in the compact space of a cramped doublewide trailer.
By Jessica Pasley